AQR Arbitrage’s Teva Pharmaceuticals TEVA Stock Holding History

AQR Arbitrage’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-75,439	Closed	-$4.7M	–	453
2015 Q1	$4.7M	Buy	+75,439	New	+$4.39M	0.06%	178

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

AQR Arbitrage's TEVA Position: Q2 2015 in Review

AQR Arbitrage sold out of Teva Pharmaceuticals (TEVA) in Q2 2015, closing a stake of 75,439 shares — an estimated $4.7M sold.

AQR Arbitrage first reported a position in TEVA in Q1 2015 and held it in 1 quarter. The position peaked at $4.7M in Q1 2015. 818 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

AQR Arbitrage reported no remaining Teva Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
AQR Arbitrage sold 75,439 Teva Pharmaceuticals shares in Q2 2015, an estimated $4.7M.
AQR Arbitrage first reported a position in Teva Pharmaceuticals in Q1 2015 and held it in 1 quarter.
AQR Arbitrage's Teva Pharmaceuticals position peaked at $4.7M in Q1 2015.
818 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2015.

Based on AQR Arbitrage's 13F filing for Q2 2015, filed 14 Aug 2015.